Evaluation of Residual Disease in Patients With Multiple Myeloma Using IMWG Flow Cytometry Criteria – The ASCO Post

By Matthew StengerPosted: 12/16/2019 10:20:00 AM Last Updated: 12/17/2019 3:31:33 PM In a study reported in the Journal of Clinical Oncology, Paiva et al examined the applicability of International Myeloma Working Group (IMWG) criteria for next-generation flow cytometry assessment of minimal…

Read the full article here

Related Articles